AI assistant
Sending…
ECB Bancorp, Inc. /MD/ — Director's Dealing 2024
May 16, 2024
33962_dirs_2024-05-16_7261b526-657b-4a06-b88d-7eabea77969b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ECB Bancorp, Inc. /MD/ (ECBK)
CIK: 0001914605
Period of Report: 2024-05-14
Reporting Person: CITRANO John A (EVP, COO and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-14 | Common Stock | P | 100 | $12.06 | Acquired | 44301 | Indirect |
| 2024-05-14 | Common Stock | P | 200 | $12.07 | Acquired | 44501 | Indirect |
| 2024-05-14 | Common Stock | P | 4 | $12.10 | Acquired | 44505 | Indirect |
| 2024-05-14 | Common Stock | P | 1008 | $12.11 | Acquired | 45513 | Indirect |
| 2024-05-14 | Common Stock | P | 88 | $12.15 | Acquired | 45601 | Indirect |
| 2024-05-15 | Common Stock | P | 199 | $12.25 | Acquired | 45800 | Indirect |
| 2024-05-15 | Common Stock | P | 200 | $12.45 | Acquired | 46000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4946 | Indirect |
| Common Stock | 59384 | Direct |
| Common Stock | 3186 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $10.1200 | 2033-10-31 | Common Stock (93610) | 93610 | Direct |
Footnotes
F1: Includes shares of restricted stock which vest at a rate of 20% per year commencing on October 31, 2024.
F2: Stock options vest at a rate of 20% per year commencing on October 31, 2024.
F3: Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
More from ECB Bancorp, Inc. /MD/
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 23
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Feb 5